“
“Aim: Inconsistent results continue to be reported in studies that examine the neural correlates of cognitive behavioral therapy (CBT) in patients with panic disorder. We examined the changes in regional cerebral blood flow (rCBF) associated with the alleviation of anxiety by CBT in panic patients.
Methods: The change in rCBF and clinical symptoms before and after CBT were assessed using single photon emission computed tomography and various clinical measures were analyzed.
Results: Fourteen subjects who completed CBT showed significant improvements
Tozasertib concentration in symptoms on clinical measures, including the Panic and Agoraphobic Scale and the Anxiety Sensitivity Index-Revised. After CBT, increased rCBF was Pitavastatin datasheet detected in the left postcentral gyrus (BA 43), left precentral gyrus (BA 4), and left inferior frontal gyrus (BA 9 and BA 47), whereas decreased
rCBF was detected in the left pons. Correlation analysis of the association between the changes in rCBF and changes in each clinical measure did not show significant results.
Conclusion: We found changes in the rCBF associated with the successful completion of CBT. The present findings may help clarify the effects of CBT on changes in brain activity in panic disorder.”
“Purpose: Oral mucositis (OM) still represents a significant complication of hematopoietic stem cell transplantations (HSCT). Observational studies focusing on risk factor definitions are still warranted.
Method: A total of 126 patients participated in this observational study after autologous HSCT with the BEAM and HD-L-PAM 200 mg/m(2) conditioning regimens. Basic clinical and laboratory variables
and their impact on OM were assessed.
Results: Age, gender, body mass index, LOXO-101 and baseline absolute neutrophil counts were not shown to have any negative impact on OM development. The multivariate analysis revealed oral cryotherapy non-provision as being the most significant predictor for OM incidence (p < 0.0001), followed by BEAM conditioning regimen (p = 0.007), OM in a patient’s history (p = 0.002) and lower number of days since the last chemotherapy (p = 0.025). The cryotherapy was remarkably effective both in the single high-dose melphalan 200 mg/m2 conditioning regimen (18% OM in cryotherapy vs. 68% without it, p <0.0001) and in the multidrug BEAM (melphalan 140 mg/m(2)) regimen (38% vs. 86%, p =0.006).
Conclusion: Oral cryotherapy should be implemented into supportive care management in patients treated with high-dose melphalan short-infusion chemotherapy. Large and well-designed randomized trials are necessary to obtain more significant and reliable results and understanding regarding OM risk factors. (C) 2011 Elsevier Ltd. All rights reserved.”
“The focus of this article of a three part series is the effects of preparation and composition on the shear rheology of cellulose in the ionic liquid 1-butyl-3-methylimidazolium chloride ([Bmim]Cl).